With the stock market gyrating and home values still falling, the retirement-age consumers who make up the bulk of Roadmaster's market are holding off on big purchases, according to David Robinson, the company's director of marketing.
If more juries follow up the decision in Texas with big awards, drug companies are likely to reassess their aggressive marketing of new drugs as soon as they come to market.